Congenital bile acid synthesis defect 4, also called CBAS4 or AMACR deficiency, is a very rare inherited disorder caused by harmful changes in the AMACR gene. This gene helps the body process special fats and make normal bile acids. When it does not work well, the body can build up toxic bile acid intermediates such as DHCA, THCA, and pristanic acid. This can lead to cholestatic liver disease, fat malabsorption, poor absorption of fat-soluble vitamins, and sometimes neurologic or eye problems. It is usually inherited in an autosomal recessive pattern. For this ultra-rare disease, the best-supported core therapy is oral cholic acid replacement, along with nutrition support and careful treatment of complications. Reviews and case series also describe low phytanic/pristanic acid diet and correction of vitamin deficiencies as important parts of care. I am keeping the article evidence-based, so I will not invent unproven “main drugs” just to fill a number.
Congenital bile acid synthesis defect 4 is a very rare inherited disease. It is also called CBAS4. In this condition, the body cannot properly make normal bile acids because both copies of the AMACR gene do not work well. Bile acids are important chemicals made by the liver. They help the body digest fat, absorb vitamins A, D, E, and K, and move bile through the liver and intestine. When this pathway is blocked, unusual bile acid building blocks and fatty acid products collect in the body, and this can damage the liver, affect nutrition, and later harm the nerves, eyes, or brain. The condition is usually inherited in an autosomal recessive way, which means a child gets one nonworking gene copy from each parent. 1 2 3
Another names
Congenital bile acid synthesis defect 4 has several other names in medical sources. These include CBAS4, bile acid synthesis defect type 4, AMACR deficiency, and alpha-methylacyl-CoA racemase deficiency. Some databases also use a long descriptive name: intrahepatic cholestasis with defective conversion of trihydroxycoprostanic acid to cholic acid. Doctors may use different names depending on whether they are focusing on the liver disease, the gene, or the metabolic pathway problem. 1 4 5
Types
There are no universally fixed formal subtypes for CBAS4 in the same way some common diseases have stages, but doctors usually describe it by pattern of presentation. The first pattern is the infantile liver form, where babies show cholestasis, vitamin deficiency, bleeding tendency, or liver test problems early in life. The second pattern is the later-onset neurologic form, where the person may present in childhood or adulthood with nerve or brain problems such as neuropathy, tremor, seizures, retinitis pigmentosa, ataxia, or encephalopathy. The third pattern is a mixed or variable form, where liver and neurologic features overlap, or where family members with the same gene change show different symptoms. This variable pattern is important because some people are very sick in infancy, while others are mild or almost silent for years. 2 5 6
Causes
The main direct cause of CBAS4 is always the same: biallelic pathogenic variants in the AMACR gene. But because you asked for 20 causes, the clearest evidence-based way is to explain the direct genetic cause plus the important disease mechanisms and inheritance factors that lead to this disorder or to its clinical picture. 2 5
-
Two nonworking AMACR gene copies cause the disease. A person usually becomes affected only when both copies are altered. 1 5
-
Autosomal recessive inheritance is the genetic pattern. This means each parent often carries one changed copy but may be healthy. 1 4
-
Homozygous variants can cause CBAS4. This means the child receives the same harmful AMACR variant from both parents. 4 5
-
Compound heterozygous variants can also cause the disease. This means each AMACR copy has a different harmful change. 1 5
-
Missense variants may cause the enzyme to be made but work poorly. This can lower enzyme activity and let toxic metabolites build up. 2 4
-
Frameshift variants can damage the gene reading frame and produce a very abnormal protein. 4
-
Nonsense variants may create a stop signal too early, so the protein is shortened and often useless. 4
-
Splice-site variants can disturb how the cell joins gene pieces together, making the final enzyme abnormal. This is a known disease mechanism in many inherited metabolic disorders and is part of AMACR-related disease testing. 1 7
-
Large deletions or duplications in AMACR may remove or disrupt important gene regions. These are checked by some molecular tests. 7 1
-
Loss of AMACR enzyme activity is the key biochemical cause. Without enough enzyme activity, normal side-chain processing of bile acid intermediates cannot continue. 2 5
-
Failure to racemize trihydroxycholestanoic acid contributes to the disorder because this step is needed before peroxisomal beta-oxidation can proceed. 2 5
-
Failure to racemize dihydroxycholestanoic acid also blocks normal bile acid formation and leads to abnormal metabolite buildup. 2 5
-
Failure to handle pristanic acid properly is another major mechanism. AMACR helps process this branched-chain fatty acid, so it rises when the enzyme fails. 2 5
-
Accumulation of DHCA is harmful because it reflects blockage of bile acid synthesis and may contribute to tissue injury. 2 5
-
Accumulation of THCA is another biochemical cause of illness in CBAS4. This abnormal intermediate appears when the pathway is blocked. 1 2
-
Low normal bile acid production leads to poor bile flow and poor digestion of fats. This helps explain cholestasis and malabsorption. 3 2
-
Toxic metabolite buildup in liver cells is a major liver injury mechanism. These intermediates can injure hepatocytes and worsen cholestasis. 3 2
-
Fat-soluble vitamin malabsorption causes many secondary problems, especially vitamin K deficiency with bleeding and vitamin E deficiency with nerve problems. 1 2
-
Consanguinity can increase the chance that both parents carry the same rare AMACR variant, so it is an important family risk factor in some cases. 5
-
Family history of AMACR deficiency or unexplained neonatal cholestasis/neuropathy raises the chance of this diagnosis, because relatives may carry the same recessive variants. 5 7
Symptoms
-
Cholestatic jaundice means yellow skin or yellow eyes due to poor bile flow. In babies, this may be one of the first clues. 1 2
-
Dark urine can happen when bilirubin increases and is passed into the urine. 2 3
-
Pale or light-colored stool may appear because less bile reaches the intestine. 3 8
-
Poor growth or failure to thrive can happen because fat and vitamins are not absorbed well. 3 8
-
Easy bruising is common when vitamin K is low and blood clotting becomes weak. 1 5
-
Bleeding tendency may become serious, including internal bleeding, because clotting factors depend on vitamin K. 2 4
-
Abdominal swelling or distension can happen from liver disease or enlarged liver and spleen. 5 3
-
Hepatomegaly means an enlarged liver. A doctor may feel this on examination. 3 5
-
Hepatosplenomegaly means both liver and spleen are enlarged. This has been described in some affected children. 5 3
-
Fat malabsorption can cause greasy stool, poor weight gain, and low vitamin levels. 1 3
-
Peripheral neuropathy is an important later symptom. It means nerve damage causing numbness, weakness, or trouble walking. 3 5
-
Ataxia or poor balance can happen when the nervous system is affected. 5 9
-
Tremor is a shaking movement that has been reported in adult-onset disease. 5 9
-
Seizures or encephalopathy may occur in some patients, especially in later neurologic disease. 5 10
-
Retinal disease or retinitis pigmentosa with visual problems can be part of the neurologic form. Some patients also have retinal dysfunction before obvious symptoms. 5 11
Diagnostic tests
Physical exam tests
-
General physical examination is the first step. The doctor looks for jaundice, poor growth, bruising, swelling, weakness, and signs of chronic liver disease. This simple exam helps guide all later tests. 3 8
-
Liver size examination is done by feeling the abdomen. An enlarged liver can suggest cholestatic or metabolic liver disease. 3 5
-
Spleen size examination is also important. If the spleen is enlarged, it may support ongoing liver disease or portal pressure changes. 5 3
-
Skin and bleeding exam looks for bruises, petechiae, or other bleeding signs from vitamin K deficiency and clotting problems. 1 2
Manual tests
-
Neurologic bedside examination checks strength, reflexes, sensation, tone, gait, and coordination. This is important because CBAS4 can later present with neuropathy or cerebellar signs. 5 6
-
Gait assessment is a simple walking test. Trouble walking may suggest neuropathy or ataxia. 5 9
-
Coordination testing such as finger-to-nose or heel-to-shin can show cerebellar involvement. 5 9
-
Eye and vision examination is useful because retinal disease has been reported. This may include visual acuity and retinal review by an eye specialist. 11 5
Lab and pathological tests
-
Liver function tests such as AST, ALT, bilirubin, and related chemistry are basic tests that often show liver injury or cholestasis. 1 3
-
Serum bile acid testing may show low or inappropriately low normal bile acids for a cholestatic patient, which can be a clue to a bile acid synthesis defect. 1 3
-
Coagulation tests such as prothrombin time and partial thromboplastin time are important because vitamin K deficiency can make them abnormal. 1 2
-
Fat-soluble vitamin level testing checks vitamins A, D, E, and K related markers. Low values support malabsorption from poor bile acid production. 1 2
-
Serum pristanic acid level is a key metabolic test. High pristanic acid strongly supports AMACR deficiency. 2 5
-
Urine bile acid analysis by mass spectrometry is one of the most important diagnostic tests. It can show abnormal bile acid intermediates that point to this pathway defect. 8 2
-
Plasma or serum DHCA and THCA measurement can detect the abnormal intermediates that build up when AMACR is deficient. 2 5
-
Molecular genetic testing of AMACR is a confirmatory test. It may use full gene sequencing, targeted analysis, or deletion and duplication testing. 1 7
-
Liver biopsy may be used when diagnosis is unclear. It can show cholestasis, giant cell change, necrotic hepatocytes, steatosis, or other liver injury patterns. 2 5
Electrodiagnostic tests
-
Nerve conduction studies help check for peripheral neuropathy in older children or adults with weakness, numbness, or gait problems. 6 12
-
Electromyography can support neuropathy or muscle involvement when neurologic symptoms are present. It is not always needed in infants, but it can help in adult-onset disease. 6 12
Imaging tests
-
Imaging studies such as abdominal ultrasound for liver and spleen size and brain MRI for neurologic cases are very useful supportive tests. Ultrasound helps look at liver disease, while MRI may show brain signal changes in later-onset AMACR deficiency. 8 9 12
Non-Pharmacological Treatments
1. Specialist metabolic-hepatology follow-up. This is the foundation of care. A liver specialist and metabolic specialist watch growth, liver tests, clotting, vitamin levels, stool fat loss, and neurologic signs. The purpose is early detection of worsening disease. The mechanism is simple: frequent review helps doctors adjust bile acid therapy, diet, and supplements before toxic metabolites cause more damage.
2. Low phytanic acid diet. AMACR deficiency can lead to accumulation of branched-chain fats, so reducing foods rich in phytanic acid can lower metabolic stress. The purpose is to reduce toxic fatty acid build-up. The mechanism is decreased intake of substrates that the body cannot handle well. This is usually done by limiting high-fat dairy, ruminant meat, and some fatty animal foods under dietitian guidance.
3. Low pristanic acid exposure. Pristanic acid can also build up in this disorder. The purpose is to reduce nerve, liver, and retina stress. The mechanism is similar to the low phytanic diet: fewer harmful substrates enter the body, so less accumulation occurs. This is not a general healthy diet for everyone; it should be personalized by an experienced metabolic dietitian.
4. Energy-rich nutrition plan. Many patients have fat malabsorption, poor weight gain, or chronic illness. The purpose is to prevent malnutrition and support growth. The mechanism is steady intake of enough calories, often with foods that are easier to digest and absorb. When the body is better nourished, healing, immunity, and development usually improve.
5. Fat-soluble vitamin monitoring. Vitamins A, D, E, and K may become low because bile acids are needed for fat absorption. The purpose is to catch deficiency early, before vision, bone, nerve, or bleeding problems appear. The mechanism is regular blood testing followed by targeted replacement. Monitoring matters because symptoms can stay hidden until deficiency is already severe.
6. Dietitian-guided fat intake adjustment. Some patients do better when total fat intake is planned carefully instead of eating large random amounts of fat. The purpose is to reduce steatorrhea and improve nutrition. The mechanism is matching fat intake to what the bowel can handle, while still providing enough calories for health and growth.
7. Small, frequent meals. Smaller meals may be easier to digest than very large meals. The purpose is to reduce bloating, oily stools, nausea, and poor appetite. The mechanism is gentler delivery of fat and calories to the gut over time, which may improve tolerance in people with bile-related malabsorption.
8. Monitoring stool pattern and steatorrhea. Tracking oily stools, pale stools, diarrhea, and weight change helps guide treatment. The purpose is practical home monitoring. The mechanism is that changes in stool often reflect changes in bile flow, absorption, or treatment response before blood tests are repeated.
9. Growth monitoring in children. Babies and children can fall behind in weight and height if fat absorption is poor. The purpose is to protect long-term development. The mechanism is regular measurement of weight, height, and developmental milestones so nutrition can be improved early.
10. Bone health surveillance. Vitamin D deficiency and fat malabsorption can weaken bones. The purpose is to prevent rickets, osteopenia, and fractures. The mechanism is checking vitamin D status, calcium intake, growth, and sometimes bone imaging when needed.
11. Eye examinations. AMACR deficiency may affect the retina even when vision symptoms are not obvious. The purpose is early detection of retinal dysfunction. The mechanism is regular eye review, which can reveal silent damage and help doctors judge whether dietary control and medical treatment are enough.
12. Neurologic assessment. Some patients develop ataxia, neuropathy, memory problems, seizures, or other neurologic features. The purpose is to identify brain and nerve involvement early. The mechanism is neurologic examination, functional testing, and follow-up over time, because this disease can change slowly.
13. Liver function surveillance. Repeated liver tests are a core non-drug treatment step. The purpose is to see whether the liver is healing or worsening. The mechanism is serial monitoring of AST, ALT, GGT, bilirubin, INR, and clinical signs such as jaundice or enlarged liver.
14. Family screening and genetic counseling. Because the disease is inherited, siblings may also be affected. The purpose is early diagnosis in relatives and better family planning. The mechanism is gene testing and counseling, which can find affected family members even before serious symptoms begin.
15. Physical therapy. If weakness, poor balance, neuropathy, or ataxia appears, physical therapy may help maintain mobility. The purpose is safer walking and better daily function. The mechanism is guided strengthening, balance work, and movement training that reduce deconditioning.
16. Occupational therapy. People with neurologic involvement may struggle with daily tasks. The purpose is to improve independence in eating, dressing, writing, and school or work tasks. The mechanism is adaptive training and tools that reduce disability from nerve or coordination problems.
17. Developmental support in children. Some children may need speech, feeding, or developmental therapy. The purpose is better long-term learning and function. The mechanism is early intervention while the brain is still developing, especially if nutrition and neurologic symptoms have affected progress.
18. Avoiding alcohol and liver toxins. An already stressed liver is more vulnerable to extra injury. The purpose is to protect remaining liver function. The mechanism is lowering additional inflammatory or toxic burden from alcohol, unnecessary herbal products, and hepatotoxic drugs unless a doctor says they are essential.
19. Vaccination and infection prevention. Good liver care includes preventing infections that can worsen liver disease or nutrition. The purpose is to reduce illness-related setbacks. The mechanism is routine vaccination, hand hygiene, and rapid treatment of infections that can trigger dehydration, poor feeding, or liver stress.
20. Early transplant referral when disease is advanced. Liver transplant is not the first treatment, but it can be life-saving in severe liver failure or cirrhosis. The purpose is survival and restoration of liver function when medical care is not enough. The mechanism is replacement of the failing liver with a healthy donor liver.
Drug Treatments
The best-supported disease-specific drug is cholic acid (CHOLBAM). The FDA label states it is indicated for bile acid synthesis disorders due to single enzyme defects and recommends 10 to 15 mg/kg/day, once daily or in two divided doses, with close monitoring of liver tests and clotting markers. Its purpose is to replace missing primary bile acid, improve bile flow, improve fat absorption, and suppress production of toxic abnormal bile acids. Common practice is specialist supervision only.
Ursodiol (ursodeoxycholic acid) is not FDA-approved for CBAS4; its label is for primary biliary cholangitis. Still, it is sometimes discussed in bile-acid disorders and cholestatic care because it becomes a major bile acid during chronic dosing and can influence bile composition. In CBAS4, it is a case-by-case supportive choice, not the main evidence-based replacement therapy.
Vitamin K replacement is often needed when cholestasis causes poor absorption and bleeding risk. Its purpose is to improve clotting. The mechanism is restoration of vitamin K–dependent clotting factor activity. This is supportive treatment, not correction of the genetic defect. Dosing depends on age, severity, labs, and route of administration decided by the treating team.
Vitamin A replacement may be required if low bile acids cause poor absorption of fat-soluble vitamins. Its purpose is eye, skin, and immune support. The mechanism is correction of deficiency, which may help vision and epithelial health. It must be monitored carefully because both deficiency and excess can be harmful, especially in liver disease.
Vitamin D replacement is used when bone health is at risk. Its purpose is support of calcium balance and bone mineralization. The mechanism is correction of deficiency caused by fat malabsorption. Severe deficiency may lead to rickets or weak bones, so blood level monitoring matters.
Vitamin E replacement may help when deficiency contributes to neurologic problems. Its purpose is antioxidant and nerve support. The mechanism is correction of low tissue vitamin E caused by poor fat absorption. In cholestatic disease, deficiency can be clinically important even before major symptoms appear.
There are no proven “immunity booster,” regenerative, or stem-cell drugs specifically approved for CBAS4 as of March 2026. For this condition, evidence-based care centers on bile acid replacement, diet, vitamin correction, monitoring, and liver transplantation when needed. Claims about special immune boosters or stem-cell cures are not supported by the rare-disease and FDA sources reviewed here.
Dietary Molecular Supplements
1. Vitamin A, 2. Vitamin D, 3. Vitamin E, and 4. Vitamin K are the most important supplements because bile acid problems commonly reduce absorption of these four vitamins. Their shared purpose is to correct malabsorption-related deficiency. Their mechanism is direct replacement of missing nutrients that support vision, bone, nerves, and clotting.
5. Calcium is often paired with vitamin D when bone strength is a concern. 6. Medium-chain triglyceride support may be used in some patients because it can be easier to absorb than long-chain fat. 7. High-calorie oral nutrition formulas may help growth and weight gain in children with chronic malabsorption.
8. Zinc, 9. selenium, and 10. omega-3 nutrition support may be considered only when poor intake, deficiency, or special nutritional needs are documented. These are not disease-specific cures. They are supportive tools used by a dietitian or metabolic team to improve nutritional status, wound healing, and overall health when intake is poor.
Surgeries or Procedures
1. Liver transplantation is the main major procedure when cirrhosis, liver failure, or uncontrolled cholestatic liver disease develops. It is done to replace a failing liver and may be life-saving.
2. Liver biopsy is sometimes done as a diagnostic procedure when the cause of cholestasis is unclear. It is done to assess injury, fibrosis, and other liver pathology.
3. Feeding tube placement may be used in severe poor growth or feeding difficulty. It is done to provide reliable nutrition when oral intake is not enough.
4. Cataract surgery may be needed in the small number of patients who develop cataracts severe enough to affect sight. It is done to improve vision.
5. Gallstone-related procedures can be required if symptomatic cholelithiasis occurs. They are done to treat pain, obstruction, or infection caused by stones.
Prevention Steps
Early diagnosis, early start of cholic acid, strict follow-up, low phytanic/pristanic diet when advised, correction of vitamin deficiencies, regular liver tests, eye checks, neurologic review, family screening, and avoiding liver toxins are the best prevention steps. They do not prevent the gene disorder itself, but they may prevent complications such as liver damage, poor growth, bone disease, bleeding, and silent retinal injury.
When to See a Doctor
See a doctor urgently for jaundice, pale stool, dark urine, bleeding, easy bruising, poor weight gain, severe diarrhea, repeated vomiting, belly swelling, confusion, seizures, balance trouble, new vision problems, or strong tiredness. In a baby, poor feeding or failure to grow needs quick review. These can signal worsening cholestasis, vitamin deficiency, or neurologic involvement.
What to Eat and What to Avoid
Good choices usually include regular balanced meals, dietitian-guided calories, prescribed vitamin supplements, and any medically advised formula or easier-to-absorb fat plan. Foods often limited when AMACR deficiency is confirmed include high-fat dairy, ruminant meat, and other foods rich in phytanic or pristanic acid, because these may worsen metabolite accumulation. Avoid alcohol and unapproved supplements that claim to “clean the liver” or “cure rare metabolic disease.”
FAQs
What causes this disease? Harmful variants in the AMACR gene.
Is it inherited? Yes, usually autosomal recessive.
Is it a liver disease only? No. It can affect liver, nutrition, nerves, and eyes.
What is the main approved treatment? Oral cholic acid.
Can diet help? Yes, especially low phytanic/pristanic intake when advised.
Why are vitamins important? Because fat-soluble vitamin deficiency is common.
Can adults have it? Yes. Some patients present later with neurologic disease.
Can babies have it? Yes. Infants may show cholestasis or coagulopathy.
Are eye problems possible? Yes, including retinal dysfunction and sometimes cataract.
Is there a cure? There is no simple gene cure yet; treatment aims to control disease and complications.
Do all patients need transplant? No. Only severe liver disease may need it.
Can supplements replace cholic acid? No. Vitamins help deficiencies, but they do not replace missing bile acid.
Should family members be tested? Often yes, especially siblings.
Can this be missed for years? Yes. Some cases are diagnosed late because symptoms vary.
Why is expert care important? Because the disease is ultra-rare and treatment must be individualized and closely monitored.
Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.
The article is written by Team RxHarun and reviewed by the Rx Editorial Board Members
Last Updated: March 12, 2025.
